These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18713014)

  • 21. MEK inhibition impairs influenza B virus propagation without emergence of resistant variants.
    Ludwig S; Wolff T; Ehrhardt C; Wurzer WJ; Reinhardt J; Planz O; Pleschka S
    FEBS Lett; 2004 Mar; 561(1-3):37-43. PubMed ID: 15013748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering signaling pathways in vivo: the Ras/Raf/MEK/ERK cascade.
    Galabova-Kovacs G; Baccarini M
    Methods Mol Biol; 2010; 661():421-31. PubMed ID: 20811999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade.
    Lu KT; Cheng NC; Wu CY; Yang YL
    Crit Care Med; 2008 Mar; 36(3):917-22. PubMed ID: 18431281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.
    Fan F; Feng L; He J; Wang X; Jiang X; Zhang Y; Wang Z; Chen Y
    Carcinogenesis; 2008 Jun; 29(6):1157-63. PubMed ID: 18515281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating signals from RTKs to ERK/MAPK.
    McKay MM; Morrison DK
    Oncogene; 2007 May; 26(22):3113-21. PubMed ID: 17496910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BuCy RAFs drive cells into MEK addiction.
    Rapp UR; Götz R; Albert S
    Cancer Cell; 2006 Jan; 9(1):9-12. PubMed ID: 16413467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipase Cgamma1 stimulates transcriptional activation of the matrix metalloproteinase-3 gene via the protein kinase C/Raf/ERK cascade.
    Shin SY; Choi HY; Ahn BH; Min do S; Son SW; Lee YH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):611-6. PubMed ID: 17196935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KSR regulation of the Raf-MEK-ERK cascade.
    Ritt DA; Daar IO; Morrison DK
    Methods Enzymol; 2006; 407():224-37. PubMed ID: 16757327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of protein l-isoaspartyl (d-aspartyl) methyltransferase results in hyperactivation of EGF-stimulated MEK-ERK signaling in cultured mammalian cells.
    Kosugi S; Furuchi T; Katane M; Sekine M; Shirasawa T; Homma H
    Biochem Biophys Res Commun; 2008 Jun; 371(1):22-7. PubMed ID: 18381200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft für Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels.
    Dumaz N; Marais R
    FEBS J; 2005 Jul; 272(14):3491-504. PubMed ID: 16008550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.
    Lorenz K; Schmitt JP; Vidal M; Lohse MJ
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2351-5. PubMed ID: 19666137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
    Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the RAF-MEK-ERK pathway in cancer therapy.
    Montagut C; Settleman J
    Cancer Lett; 2009 Oct; 283(2):125-34. PubMed ID: 19217204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade.
    Marjuki H; Yen HL; Franks J; Webster RG; Pleschka S; Hoffmann E
    Virol J; 2007 Dec; 4():134. PubMed ID: 18053252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ras-sensitive IMP modulation of the Raf/MEK/ERK cascade through KSR1.
    Matheny SA; White MA
    Methods Enzymol; 2006; 407():237-47. PubMed ID: 16757328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F5 and LEK1 translocation to the nucleus is an early event demarcating myoblast quiescence.
    Reed SA; Ouellette SE; Liu X; Allen RE; Johnson SE
    J Cell Biochem; 2007 Aug; 101(6):1394-408. PubMed ID: 17295207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Raf/MEK/ERK pathway in pituitary adenomas.
    Suojun Z; Feng W; Dongsheng G; Ting L
    Eur J Cancer; 2012 Feb; 48(3):389-95. PubMed ID: 22119203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells.
    Ma J; Li F; Liu L; Cui D; Wu X; Jiang X; Jiang H
    Liver Int; 2009 Apr; 29(4):567-74. PubMed ID: 19323783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.